So far, azacitidine can improve the expression level of GADD45γ by changing the methylation level of GADD45γ gene, promote cell apoptosis, promote MDS cell line apoptosis, and finally achieve the effect of MDS disease treatment. The gene discussed is GADD45G; the disease is myelodysplastic syndrome.